HR

Hina Ravindra Mehta

Active Director Director DIN 08719453
DIN 08719453 First appointment Mar 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Hina Ravindra Mehta

Data last updated:

Hina Ravindra Mehta is a Director at Jenburkt Pharmaceuticals Ltd (since 2020). The company operates in Pharma. Jenburkt Pharmaceuticals Ltd reported revenue of ₹158 Cr (FY 2025).

DIN 08719453
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 2020
Oldest Company Age 41 yrs
Largest company Jenburkt Pharmaceuticals Ltd · ₹158 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jenburkt Pharmaceuticals Ltd L24230MH1985PLC036541
Director28 Mar 20201985₹158 Cr (FY 2025)Active

Board colleagues of Hina Ravindra Mehta

Directorship timeline

Open interactive timeline →
Jenburkt Pharmaceuticals Ltd
Premium access

Shareholding and investment profile for Hina Ravindra Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hina Ravindra Mehta

Hina Ravindra Mehta currently holds 1 directorship: Jenburkt Pharmaceuticals Ltd (Director, since 28 Mar 2020, revenue ₹158 Cr (FY 2025)).

Hina Ravindra Mehta was first appointed on 28 Mar 2020 as Director at Jenburkt Pharmaceuticals Ltd.

The current boards of Hina Ravindra Mehta's companies include Ashish Rasiklal Shah (Jenburkt Pharmaceuticals Ltd), Ashish Uttam Bhuta (Jenburkt Pharmaceuticals Ltd), Dilip Harkishandas Bhuta (Jenburkt Pharmaceuticals Ltd), Dilip Harkishandas Bhuta (Jenburkt Pharmaceuticals Ltd), Krishnan Subharaman (Jenburkt Pharmaceuticals Ltd), Pankaj Arun Dantwala (Jenburkt Pharmaceuticals Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available